Clinical diagnosis of heterozygous dystrophin gene deletions by fluorescence in situ hybridization

Neuromuscular Disorders

Volumn 8, Issue 7, 1998, Pages 447-452

  Rosenberg, C ^a,b   Navajas, L ^b   Vagenas, D F ^b   Bakker, E ^a   Vainzof, M ^b   Passos Bueno, M R ^b   Takata, R I ^b   Van Ommen, G J B ^a   Zatz, M ^b   Den Dunnen, J T ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Deletions; Diagnosis; Duchenne muscular dystrophy (DMD); Fluorescence in situ hybridization (FISH); Heterozygote

Indexed keywords

DYSTROPHIN;

ARTICLE; BECKER MUSCULAR DYSTROPHY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; COSMID; DUCHENNE MUSCULAR DYSTROPHY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; HETEROZYGOTE; HUMAN; HUMAN TISSUE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; TECHNIQUE;

DNA PROBES; DYSTROPHIN; EXONS; GENE DELETION; GENES; HETEROZYGOTE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MUSCULAR DYSTROPHIES;

EID: 0032190912     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(98)00050-9     Document Type: Article

References (15)

1. [1] Feener CA, Koenig M, Kunkel LM. Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus. Nature 1989;338:509-511.
2. [2] Monaco AP, Neve RL, Colletti-Feener C, Bertelson CJ, Kurnit DM, Kunkel LM. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 1986;323:646-650.
3. [3] Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener CA, Kunkel LM. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987;50:509-517.
4. [4] Den Dunnen JT, Grootscholten PM, Bakker E, et al. Topography of the DMD gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet 1989;45:835-847.
5. [5] Chamberlain JS, Gibbs RA, Ranier JE, Nga Nguyen PN, Caskey CT. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucl Acids Res 1988;23:11141-11156.
6. [6] Beggs AH, Koenig M, Boyce FM, Kunkel LM. Detection of 98-percent DMD/BMD gene deletions by polymerase chain reaction. Hum Genet 1990;86:45-48.
7. [7] Beggs AH. Multiplex PCR for identifying dystrophin gene deletions. Anon Curr Protocols Hum Genet 1994:9.3.1-9.3.17.
8. [8] Yau SC, Bobrow M, Mathew CG, Abbs SJ. Accurate diagnosis of carriers of deletions and duplications in Duchenne/Becker muscular dystrophy by fluorescent dosage analysis. J Med Genet 1996;33:550-558.
9. [9] Gelfi C, Orsi A, Leoncini F, et al. Amplification of 18 dystrophin gene exons in DMD/BMD patients: simultaneous resolution by capillary electrophoresis in sieving liquid polymers. BioTechniques 1995;19:254-263.
10. [10] Van Ommen GJB, Breuning MH, Raap AK. FISH in genome research and molecular diagnostics. Curr Opin Genet Dev 1995; 5:304-308.
11. [11] Ried T, Mahler V, Vogt P, et al. Direct carrier detection by in situ suppression hybridization with cosmid clones of the Duchenne/ Becker muscular dystrophy locus. Hum Genet 1990;85:581-586.
12. [12] Voskova-Goldman A, Peier A, Caskey CT, Richards CS, Shaffer LG. DMD-specific FISH probes are diagnostically useful in the detection of female carriers of DMD gene deletions. Neurology 1997;48: 1633-1638.
13. [13] Takata RI. Estudos de deleções moleculares com sondas de cDNA ao longo do gene da distrofina. Ph.D. Thesis, São Paulo, 1994.
14. [14] Den Dunnen JT, Bakker E. The Leiden Muscular Dystrophy data pages. http://www.dmd.nl, 1997.
15. [15] Jennekens FGI, Ten Kate LP, De Visser M, Wintzen AR. Diagnostic criteria for Duchenne and Becker muscular dystrophy and myotonic dystrophy. Neuromusc Disord 1991;1:389-391.